William L. Berry

Approaches to mass customization: configurations and empirical validation

Rebecca Duray, Peter T. Ward, Glenn W. Milligan et al. · Journal of Operations Management · 2000 · 712 citations

Engineering, Industrial Engineering, Manufacturing Engineering +17

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA)

Bethany N. Hannafon, Karla J. Carpenter, William L. Berry et al. · Molecular Cancer · 2015 · 218 citations · Full text

Medicine, Cancer Biology, Oncology +17

A mapping of competitive priorities, manufacturing practices, and operational performance in groups of Danish manufacturing companies

Thomas Bøhm Christiansen, William L. Berry, Peter Bruun et al. · International Journal of Operations & Production Management · 2003 · 165 citations

Management, Strategic Management, Strategy +17

Manufacturing flexibility: methods for measuring the impact of product variety on performance in process industries

William L. Berry, Martha C. Cooper · Journal of Operations Management · 1998 · 161 citations

Management, Strategic Management, Strategy +15